Revolution (RVMD) PT Raised to $265 at UBS as Daraxonrasib Pricing Announced
Tweet Send to a Friend
UBS analyst Michael Yee raised the price target on Revolution (NASDAQ: RVMD) to $265.00 (from $220.00) while maintaining a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
